// App-Quantinova.ai

6256 : Longitudinal transcriptional profiling of CTCs in metastatic breast cancer patients receiving CDK4/6 inhibitors to predict response

Researchers

Presenter

  • Corinna Keup

Principal Investigators

  • Charlotte Gruber

  • Oliver Hoffmann

  • Rainer Kimmig

  • Sabine Kasimir-Bauer

Medical Centers

  • University Hospital of Essen, Essen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Protein Tyrosine Phosphatase, Receptor Type C

  • Cyclin-dependent kinase 4

Drug/Treatment

  • Palbociclib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved